IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $165,000 | +83.3% | 3,740 | +54.1% | 0.01% | +100.0% |
| Q1 2022 | $90,000 | +150.0% | 2,427 | +104.3% | 0.00% | +200.0% |
| Q4 2021 | $36,000 | -2.7% | 1,188 | +50.2% | 0.00% | -93.8% |
| Q1 2020 | $37,000 | -84.4% | 791 | -79.9% | 0.02% | -71.4% |
| Q4 2019 | $237,000 | +618.2% | 3,929 | +879.8% | 0.06% | +330.8% |
| Q1 2019 | $33,000 | -70.0% | 401 | -83.9% | 0.01% | -77.2% |
| Q1 2018 | $110,000 | +214.3% | 2,498 | +255.8% | 0.06% | +111.1% |
| Q4 2017 | $35,000 | +288.9% | 702 | +75.5% | 0.03% | +170.0% |
| Q2 2016 | $9,000 | -64.0% | 400 | 0.0% | 0.01% | -88.0% |
| Q4 2015 | $25,000 | – | 400 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |